Table 2.

Enrichment of cell types in each condition and menstrual phase and their fluctuation throughout the menstrual cycle.

Population (Signif. Stages Strat.When not both)	Disease vs Control		Variation across the cycle
	Enriched in	Signif.	Control			Endo
		Phase
		Strat.	PE	ESE	MSE	PE	ESE	MSE
γδTcells	Control (n = 34)	PE	+++ ◊	++~	+ ◊~	++	++	++
CD4+ memory T cells		PE	+++	+++	+++	+ ◊	+++	++ ◊
Th2 cells		PE, ESE	+++ ◊	+++~	+ ◊ ~	++ ◊	++	+ ◊
DC	Endo (n = 71)	All	+	+	++	+++ ◊	++ ◊	+++
iDC (stages III-IV)		PE	+++ *◊	++ *	++ ◊	+++ *◊	++ *	++ ◊
aDC		All	+	+	++	+++	++	+++
pDC		PE, MSE	+ ◊	+	++ ◊	++ ◊	++ ~	+++ ◊~
Monocytes		PE, MSE	+	+	+	++ ◊	+ ~	++ ◊~
Macrophages		PE, MSE	+ ◊	+ ~	++ ◊~	++ ◊	++ ~	+++ ◊~
Macrophages M1		All	+	+ ~	++ ~	+++	++ ~	+++ ~
Macrophages M2		All	+ ◊	+ ~	++ ◊~	+++ *	++ *~	+++ *~
NK cells (Stages III-IV)		None	+ ◊	+	++ ◊	+ ◊	++ ~	+++ ◊~
Neutrophils		PE	+	+	+	+	+	+
Eosinophils		All	+ ◊	+	++ ◊	++ *	+ *	++
Basophils		PE, MSE	+ ◊	++	+++ ◊	+++	++ ~	+++ ~
CD8+ Tem		All	+ ◊	+ ~	++ ◊~	++ ◊	++ ~	+++ ◊~
CD4+ naïve		PE, ESE	+ ◊	+ ~	+++ ◊~	++ ◊	++ ~	+++ ◊~
CD4+ Tcm		PE, ESE	+ ◊	+ ~	+++ ◊~	++	++ ~	+++ ~
CD4+ Tem		All	+ ◊	+ ~	++ ◊~	+++ *	++ *~	+++ ~
Th1 (stages I-II)		PE, MSE	+++ ◊	++	+ ◊	+++ *◊	++ *	++ ◊
Endothelial cells		PE	++	++	++	+++	++	+++
mv Endothelial		All	+	+ ~	++ ~	+++ *	++* ~	+++ ~
ly Endothelial		All	++ *	+ *	+	+++ *	++ *	+++
Epithelial cells		PE, MSE	+ ◊	++	+++ ◊	+ ◊	++ ~	+++ ◊~
Keratinocytes		All	+ ◊	++	+++ ◊	+++	++	+++
Skeletal muscle cells		PE, MSE	+	+	+	++	++	++
Neurons (phase strats only)		PE, MSE	+++ ◊*	++ *	+ ◊	++ *◊	+ *	+ ◊
Astrocytes (phase strats only)		MSE	+++ ◊	++	+ ◊	+++ *◊	++ *	++ ◊
Erythrocytes (phase strats)		MSE	+++ ◊	++ ~	+ ◊~	++ ◊	++	+ ◊
MPP		All	+ ◊	+ ~	++ ◊~	++	+ ~	++ ~
HSC		PE, ESE	+ *◊	++ *	+++ ◊	+++	+++	+++

Significant differences between: * = PE and ESE; ~ = ESE and MSE; ◊ = PE and MSE.

Abundance of the cell type = +/++/+++.

Unstrat., Unstratified.